Inhibikase Therapeutics, Inc. · NASDAQ:IKT

BlackRock, Inc. reported a 5.90% stake in Inhibikase Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Jul 28, 2026

BlackRock, Inc. reported a 5.90% stake in Inhibikase Therapeutics, Inc., 7,768,004 shares, as a passive investor on Jun 30, 2026. Filed Jul 28, 2026 (Schedule 13G).

Stake
5.90%
Shares
7,768,004
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.5.90%7,768,004

Source

View original at SEC

Related